Displaying 25 - 36 of 48
Immune-Mediated and Cholestatic Diseases

Should we focus on monitoring ALP?

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure

Overview of HBV antigens and relevance to functional cure

Webcasts
View
Viral Hepatitis
Discussion / Q&A

Discussion / Q&A

Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?

Modulating systemic inflammation: how does Albumin work?

Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?

How do patients benefit from Albumin?

Webcasts
View
Cirrhosis & Complications
Summary and Conclusions “from a fluid to a  medicine”

Summary and Conclusions “from a fluid to a  medicine”

Webcasts
View
Displaying 25 - 36 of 48